United States Biotechnology & Medical Research

Better Therapeutics Inc (BTTX)

Track

Ticker: BTTX Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Better Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 27 Jul 2023
Value US$2,997,331.40 | Price 283.98 | Shares 27,829 (-25.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-31 2023-07-27 B Purchase
1.2
KARBE FRANK

Chief Executive Officer

Executive Director
27,829 -25.2%
283.98
US$2,997,331 		27,829 -25.2% 283.98 US$2,997,331
2023-07-31 2023-07-27 B Purchase
1.5
PERRY DAVID P

Executive Chairman

Executive Director Large shareholder
24,975 -6.1%
249.12
US$3,838,388 		24,975 -6.1% 249.12 US$3,838,388
2023-07-31 2023-07-27 B Purchase
1.9
Parker Geoffrey M.
Non-Executive Director
27,425 +31.0%
455.18
US$781,689 		27,425 +31.0% 455.18 US$781,689
2023-07-31 2023-07-27 B Purchase
Granger Elder
Non-Executive Director
34,251 +2140.7%
0.73
US$25,000 		34,251 +2140.7% 0.73 US$25,000
2023-07-31 2023-07-27 B Purchase
3.4
Armanino Andrew J.
Non-Executive Director
274,010 +60.3%
0.73
US$200,000 		274,010 +60.3% 0.73 US$200,000
2023-07-31 2023-07-27 B Purchase
Berman Mark A.

Chief Medical Officer

Officer
54,802 +16.4%
0.73
US$40,000 		54,802 +16.4% 0.73 US$40,000
2023-05-18 2023-05-16 B Purchase
Granger Elder
Non-Executive Director
600 +60.0%
0.87
US$520 		600 +60.0% 0.87 US$520
2023-04-12 2023-04-10 B Purchase
3.4
Armanino Andrew J.
Non-Executive Director
303,030 +200.2%
0.83
US$250,000 		303,030 +200.2% 0.83 US$250,000
2023-04-12 2023-04-10 B Purchase
1.9
Parker Geoffrey M.
Non-Executive Director
303,030 +757.6%
0.83
US$250,000 		303,030 +757.6% 0.83 US$250,000
2023-04-12 2023-04-10 B Purchase
1.2
KARBE FRANK

See Remarks

Executive Director
242,424 +484.8%
0.83
US$200,000 		242,424 +484.8% 0.83 US$200,000
2023-04-12 2023-04-10 B Purchase
1.5
PERRY DAVID P

See Remarks

Executive Director Large shareholder
3,636,364 +inf%
0.83
US$3,000,000 		3,636,364 +inf% 0.83 US$3,000,000
2023-04-12 2023-04-10 B Purchase
1.5
PERRY DAVID P

See Remarks

Executive Director Large shareholder
1,333,333 +12.7%
0.83
US$1,100,000 		1,333,333 +12.7% 0.83 US$1,100,000
2022-09-19 2022-09-16 B Purchase
1.5
PERRY DAVID P

See Remarks

Executive Director Large shareholder
39,156 +62.8%
2.07
US$80,975 		39,156 +62.8% 2.07 US$80,975
2022-09-19 2022-09-15 B Purchase
1.5
PERRY DAVID P

See Remarks

Executive Director Large shareholder
10,844 +21.0%
1.99
US$21,623 		10,844 +21.0% 1.99 US$21,623
2022-09-15 2022-09-15 B Purchase
1.2
KARBE FRANK

See Remarks

Executive Director
50,000 +inf%
2.09
US$104,695 		50,000 +inf% 2.09 US$104,695
2022-09-14 2022-09-13 B Purchase
0.5
Heinen Mark

See Remarks

Officer
26,132 +59.6%
1.94
US$50,696 		26,132 +59.6% 1.94 US$50,696
2022-09-14 2022-09-12 B Purchase
0.5
Heinen Mark

See Remarks

Officer
23,868 +119.3%
1.94
US$46,304 		23,868 +119.3% 1.94 US$46,304
2022-06-28 2022-06-24 B Purchase
0.5
Heinen Mark

See Remarks

Officer
2,281 +inf%
1.75
US$4,000 		2,281 +inf% 1.75 US$4,000
2022-06-16 2022-06-14 B Purchase
3.4
Armanino Andrew J.
Non-Executive Director
15,000 +inf%
1.39
US$20,846 		15,000 +inf% 1.39 US$20,846
2022-06-14 2022-06-13 B Purchase
1.9
Parker Geoffrey M.
Non-Executive Director
25,000 +166.7%
1.45
US$36,182 		25,000 +166.7% 1.45 US$36,182
2022-06-10 2022-06-10 B Purchase
0.5
Heinen Mark

See Remarks

Officer
5,000 +33.3%
1.56
US$7,800 		5,000 +33.3% 1.56 US$7,800
2022-06-10 2022-06-09 B Purchase
3.4
Armanino Andrew J.
Non-Executive Director
25,000 +19.8%
1.65
US$41,355 		25,000 +19.8% 1.65 US$41,355
2022-04-04 2022-03-31 B Purchase
Appelbaum Kevin J

Chief Executive Officer

Executive Director Large shareholder
2,500 +66.7%
1.97
US$4,921 		2,500 +66.7% 1.97 US$4,921
2022-04-04 2022-03-31 B Purchase
0.5
Heinen Mark

See Remarks

Officer
5,000 +50.0%
1.98
US$9,900 		5,000 +50.0% 1.98 US$9,900
2021-12-23 2021-12-21 B Purchase
2.7
LAVIZZO-MOUREY RISA J
Non-Executive Director
10,000 +inf%
4.60
US$46,000 		10,000 +inf% 4.60 US$46,000
2021-12-22 2021-12-20 B Purchase
Appelbaum Kevin J

Chief Executive Officer

Executive Director Large shareholder
1,000 +36.4%
4.60
US$4,600 		1,000 +36.4% 4.60 US$4,600
2021-12-17 2021-12-15 B Purchase
Appelbaum Kevin J

Chief Executive Officer

Executive Director Large shareholder
750 +37.5%
4.71
US$3,530 		750 +37.5% 4.71 US$3,530
2021-12-15 2021-12-15 B Purchase
0.5
Heinen Mark

See Remarks

Officer
2,333 +30.4%
4.70
US$10,953 		2,333 +30.4% 4.70 US$10,953
2021-12-16 2021-12-14 B Purchase
1.9
Parker Geoffrey M.
Non-Executive Director
20,000 +60.0%
4.94
US$98,800 		20,000 +60.0% 4.94 US$98,800
2021-12-15 2021-12-14 B Purchase
0.5
Heinen Mark

See Remarks

Officer
500 +7.0%
5.44
US$2,721 		500 +7.0% 5.44 US$2,721
2021-12-15 2021-12-13 B Purchase
0.5
Heinen Mark

See Remarks

Officer
500 +7.5%
5.45
US$2,725 		500 +7.5% 5.45 US$2,725
2021-12-15 2021-12-13 B Purchase
3.4
Armanino Andrew J.
Non-Executive Director
21,000 +32.1%
5.48
US$115,067 		21,000 +32.1% 5.48 US$115,067
2021-12-14 2021-12-10 B Purchase
Appelbaum Kevin J

Chief Executive Officer

Executive Director Large shareholder
1,000 +100.0%
5.98
US$5,975 		1,000 +100.0% 5.98 US$5,975
2021-12-07 2021-12-03 B Purchase
Granger Elder
Non-Executive Director
1,000 +inf%
6.66
US$6,660 		1,000 +inf% 6.66 US$6,660
2021-12-06 2021-12-03 B Purchase
Appelbaum Kevin J

Chief Executive Officer

Executive Director Large shareholder
500 +100.0%
6.43
US$3,213 		500 +100.0% 6.43 US$3,213
2021-12-06 2021-12-02 B Purchase
Appelbaum Kevin J

Chief Executive Officer

Executive Director Large shareholder
500 +inf%
6.84
US$3,420 		500 +inf% 6.84 US$3,420
2021-12-01 2021-11-29 B Purchase
3.4
Armanino Andrew J.
Non-Executive Director
17,000 +35.2%
6.96
US$118,320 		17,000 +35.2% 6.96 US$118,320
2021-11-01 2021-10-28 B Purchase
1.5
PERRY DAVID P

See Remarks

Executive Director Large shareholder
200,000 +1.9%
10.00
US$2,000,000 		200,000 +1.9% 10.00 US$2,000,000
2021-11-01 2021-05-26 B Purchase
1.5
PERRY DAVID P

See Remarks

Executive Director Large shareholder
20,000 +63.4%
9.95
US$199,000 		20,000 +63.4% 9.95 US$199,000
2021-11-01 2021-05-24 B Purchase
1.5
PERRY DAVID P

See Remarks

Executive Director Large shareholder
8,000 +34.0%
9.94
US$79,520 		8,000 +34.0% 9.94 US$79,520
2021-11-01 2021-05-21 B Purchase
1.5
PERRY DAVID P

See Remarks

Executive Director Large shareholder
8,000 +51.5%
9.95
US$79,600 		8,000 +51.5% 9.95 US$79,600
2021-11-01 2021-05-14 B Purchase
1.5
PERRY DAVID P

See Remarks

Executive Director Large shareholder
3,060 +24.5%
9.93
US$30,386 		3,060 +24.5% 9.93 US$30,386
2021-11-01 2021-05-13 B Purchase
1.5
PERRY DAVID P

See Remarks

Executive Director Large shareholder
7,000 +127.8%
9.93
US$69,510 		7,000 +127.8% 9.93 US$69,510
2021-11-01 2021-05-04 B Purchase
1.5
PERRY DAVID P

See Remarks

Executive Director Large shareholder
3,476 +173.8%
9.93
US$34,517 		3,476 +173.8% 9.93 US$34,517
2021-11-01 2021-04-30 B Purchase
1.5
PERRY DAVID P

See Remarks

Executive Director Large shareholder
2,000 +inf%
9.95
US$19,900 		2,000 +inf% 9.95 US$19,900
2021-04-09 2021-04-07 S Sale
1.9
Liu Suying

Chief Executive Officer

Executive Director Large shareholder
200,000 -12.7%
9.00
US$1,800,000 		200,000 -12.7% 9.00 US$1,800,000
2021-01-19 2021-01-14 B Purchase
2.6
Liu Dong

Chief Financial Officer

Executive Director Large shareholder
7,500 +0.5%
10.00
US$75,000 		7,500 +0.5% 10.00 US$75,000
2021-01-19 2021-01-14 B Purchase
1.9
Liu Suying

Chief Executive Officer

Executive Director Large shareholder
7,500 +0.5%
10.00
US$75,000 		7,500 +0.5% 10.00 US$75,000
2021-01-19 2021-01-14 B Purchase
1.9
Mountain Crest Capital LLC
Large shareholder
7,500 +0.5%
10.00
US$75,000 		7,500 +0.5% 10.00 US$75,000
2021-01-14 2021-01-12 B Purchase
1.9
Liu Suying

Chief Executive Officer

Executive Director Large shareholder
135,000 +9.4%
10.00
US$1,350,000 		135,000 +9.4% 10.00 US$1,350,000
2021-01-14 2021-01-12 B Purchase
2.6
Liu Dong

Chief Financial Officer

Executive Director Large shareholder
135,000 +9.4%
10.00
US$1,350,000 		135,000 +9.4% 10.00 US$1,350,000
2021-01-14 2021-01-12 B Purchase
1.9
Mountain Crest Capital LLC
Large shareholder
135,000 +9.4%
10.00
US$1,350,000 		135,000 +9.4% 10.00 US$1,350,000
Explore more

More insider trading research around Better Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America